INT17618
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
[Dynamic change of beta 2-microglobulin in hemodialysis]. | |||||||||||||||
| |||||||||||||||
|
Analysis of the sample groups together identified reduced expression stability (0.59) of the two optimal reference genes (TBP and B2M). | |||||||||||||||
| |||||||||||||||
|
However, recent studies have shown that the expression stability of some of the commonly used reference genes, such as B2M, GAPDH and ACTB is not constant for all tissues or disease states [10,11]. | |||||||||||||||
| |||||||||||||||
|
Serum beta 2-microglobulin levels in patients chronically dialyzed with CA-210 versus CT-190 dialysis membranes. | |||||||||||||||
| |||||||||||||||
|
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and beta-2-microglobulin (B2M) were selected as normaliser genes from the initial microarray filter gene expression data. | |||||||||||||||
| |||||||||||||||
|
Mean fractional excretion of beta 2-microglobulin was higher (8.61 +/- 1.76 SEM) in patients with analgesic nephropathy than in those with glomerulonephritis (1.13 +/- 0.76) (P less than 0.025). | |||||||||||||||
| |||||||||||||||
|
Beta 2-microglobulin excretion and urinary cytology in analgesic nephropathy. | |||||||||||||||
| |||||||||||||||
|
Nevertheless, reduction of the plasma beta 2-microglobulin was greater during push/pull HDF than during HD. | |||||||||||||||
| |||||||||||||||
|
[Rheumatologic and radiologic symptoms of dialysis-associated beta 2-microglobulin amyloidosis: long-term retrospective study of 175 chronic hemodialysis patients]. | |||||||||||||||
| |||||||||||||||
|
The geNorm algorithm is employed to investigate the expression stability of 9 commonly used reference genes (glyceraldehyde-3-phosphate dehydrogenase [GAPDH], beta-actin [ACTB], beta-2-microglobulin [B2M] hydroxymethylbilane synthase [HMBS], hypoxanthine guanine phosphoribosyl transferase [HPRT], ribosomal protein L13a [RPL13A], succinate dehydrogenase flavoprotein subunit A [SDHA], TATA box binding protein [TBP] and tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide [YWHAZ]) [11] in normal and diseased canine connective tissues. | |||||||||||||||
| |||||||||||||||
|
Therefore, the present study aimed to determine the expression stability of common reference genes (ACTB, Beta actin; GAPDH, Glyceraldehyde-3-phosphate; B2M, Beta-2-microglobulin; HPRT1, Hypoxanthine phosphoribosyl-transferase I; SDHA, Succinate dehydrogenase complex, subunit A; YWHAZ, Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide) under the influence of glucosamine, curcumin and diacerein in the IL-1? | |||||||||||||||
| |||||||||||||||
|
To our knowledge, only one of the reference genes (B2M) we evaluated to be consistently expressed has been reported as being differentially expressed in OA articular cartilage [30]. | |||||||||||||||
| |||||||||||||||
|
To our knowledge, only one of the reference genes (B2M) we evaluated to be consistently expressed has been reported as being differentially expressed in OA articular cartilage [30]. | |||||||||||||||
| |||||||||||||||
|
The geNorm algorithm is employed to investigate the expression stability of 9 commonly used reference genes (glyceraldehyde-3-phosphate dehydrogenase [GAPDH], beta-actin [ACTB], beta-2-microglobulin [B2M] hydroxymethylbilane synthase [HMBS], hypoxanthine guanine phosphoribosyl transferase [HPRT], ribosomal protein L13a [RPL13A], succinate dehydrogenase flavoprotein subunit A [SDHA], TATA box binding protein [TBP] and tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide [YWHAZ]) [11] in normal and diseased canine connective tissues. | |||||||||||||||
| |||||||||||||||
|
The CT results demonstrated a notable decrease in gene expression for B2M and YWHAZ from the OA sample group (Figure 2). | |||||||||||||||
| |||||||||||||||
|
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and beta-2-microglobulin (B2M) were selected as normaliser genes from the initial microarray filter gene expression data. | |||||||||||||||
| |||||||||||||||
|
Finally, our gene set contains markers for a range of different cell differentiation fates, including embryonic development (AMD1, SERPINH1), vasculogenesis (S100A4), hematopoesis (B2M, IGFBP6, IKZF5), neurogenesis (BASP1, SERPINH1), and even osteoclastogenesis (CTSB, CTSD, CTSK); it is possible that these genes are downregulated in response to our osteogenic stimulus. | |||||||||||||||
| |||||||||||||||
|
[Compensatory changes in beta 2-microglobulin handling in the remnant tubules after contralateral nephrectomy. | |||||||||||||||
| |||||||||||||||
|
In contrast, for curcumin and diacerein-treated samples, HPRT1, GAPDH and B2M provided the most stable expression levels with SDHA ranking the 6th and 5th positions, respectively. | |||||||||||||||
| |||||||||||||||
|
Therefore, the present study aimed to determine the expression stability of common reference genes (ACTB, Beta actin; GAPDH, Glyceraldehyde-3-phosphate; B2M, Beta-2-microglobulin; HPRT1, Hypoxanthine phosphoribosyl-transferase I; SDHA, Succinate dehydrogenase complex, subunit A; YWHAZ, Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide) under the influence of glucosamine, curcumin and diacerein in the IL-1? | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.